Related Experiment Video
Updated: Jun 3, 2025

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
Published on: April 3, 2016
Controversies in Myopia Control Treatment: What Does It Mean for Future Research?
Carla Lanca1, Michael X Repka2, Andrzej Grzybowski3
1From the Escola Superior de Tecnologia da Saúde de Lisboa (ESTeSL), Instituto Politécnico de Lisboa (C.L.), Lisboa, Portugal; Comprehensive Health Research Center (CHRC), Escola Nacional de Saúde Pública, Universidade Nova de Lisboa (C.L.), Lisboa, Portugal.
Current myopia control treatments face ongoing debates regarding efficacy and long-term outcomes. Further research is needed to optimize treatment strategies and address accessibility challenges for myopia management.
Area of Science:
- Ophthalmology
- Optometry
- Pediatric Eye Care
Background:
- Myopia control research spans over 30 years.
- Significant controversies persist regarding treatment duration and long-term efficacy.
Purpose of the Study:
- To outline current clinical controversies in myopia treatment.
- To identify areas needing further investigation in myopia control.
Main Methods:
- Perspective piece.
- Review of clinical trial data and studies on myopia control therapies.
Main Results:
- Efficacy debates surround low-dose atropine and new spectacle lens designs.
- Safety concerns exist for soft contact lenses, orthokeratology, and red light therapy.
- The role of outdoor time in myopia progression requires more study.
Conclusions:
- Myopia management is complex, with challenges in identifying suitable candidates and evidence gaps for certain populations.
- Cost and availability create socioeconomic barriers to treatment access.
- Ongoing research is crucial for developing better myopia control strategies.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Focusing of Light in the Eye
Glaucoma: Overview

